BMJ Best Practice
最后审核时间: 六月 2019
最近更新时间: 一月 2019

小结

鉴别诊断

常见

  •  白血病
  •  转移性恶性肿瘤
  •  霍奇金淋巴瘤
  •  非霍奇金淋巴瘤

罕见

  •  多发性骨髓瘤
  •  骨髓纤维化
  •  血栓性血小板减少性紫癜 (TTP)
  • 溶血性尿毒症综合征 (HUS)

贡献者

Associate Professor

Weill Cornell Medicine

Pathology and Laboratory Medicine

Division of Immunopathology

New York

NY

利益冲突披露
JTG declares that she has no competing interests.

Dr Julia T. Geyer would like to gratefully acknowledge Dr Alan E. Lichtin, a previous contributor to this monograph. AEL is on an advisory board and has received research support from Amgen.

同行评议专家 查看所有

Clinical Professor of Medicine

University of Texas Health Science Center

San Antonio

Cancer Care Network of South Texas

San Antonio

TX

利益冲突披露
RML declares that he has no competing interests.

Clinical Assistant Professor of Medicine

University of Connecticut School of Medicine

Farmington

CT

利益冲突披露
JSW has received research support from Amgen, Ligand Pharmaceuticals, and MGI Pharma for clinical studies in immune thrombocytopenic purpura.

Professor of Medicine

Case Western Reserve University School of Medicine

Cleveland

OH

利益冲突披露
KRM declares that he has no competing interests.

使用此内容应接受我们的免责声明